T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Royalty Pharma
RPRX
$26.4B
| $8.1M | ﹤0.01% |
286,299
+15,847
| +6% | +$439K |
|
1177
Plexus
PLXS
$7.25B
| $8.08M | ﹤0.01% |
59,124
+40,526
| +218% | +$4.92M |
|
1178
Armstrong World Industries
AWI
$7.75B
| $7.99M | ﹤0.01% |
60,794
-1,021,727
| -94% | -$126M |
|
1179
Mueller Industries
MLI
$15.1B
| $7.99M | ﹤0.01% |
215,542
+18,026
| +9% | +$604K |
|
1180
Kaspi.kz JSC
KSPI
$18.9B
| $7.92M | ﹤0.01% |
74,770
-8,190
| -10% | -$1.02M |
|
1181
Tarsus Pharmaceuticals
TARS
$3.07B
| $7.87M | ﹤0.01% |
239,315
-51,960
| -18% | -$1.46M |
|
1182
Sun Life Financial
SLF
$44.4B
| $7.84M | ﹤0.01% |
+135,168
| New | +$7.06M |
|
1183
Healthcare Realty
HR
$6.58B
| $7.8M | ﹤0.01% |
429,744
-2,903,846
| -87% | -$51.5M |
|
1184
Valmont Industries
VMI
$9.52B
| $7.74M | ﹤0.01% |
26,679
+439
| +2% | +$123K |
|
1185
OFG Bancorp
OFG
$2.26B
| $7.61M | ﹤0.01% |
169,409
+9,954
| +6% | +$428K |
|
1186
Tetra Tech
TTEK
$9.09B
| $7.59M | ﹤0.01% |
160,944
+9,549
| +6% | +$425K |
|
1187
Fulton Financial
FULT
$4.67B
| $7.57M | ﹤0.01% |
417,231
-111,034
| -21% | -$2.02M |
|
1188
Acuity Brands
AYI
$10.8B
| $7.56M | ﹤0.01% |
27,439
+3,221
| +13% | +$800K |
|
1189
ITT
ITT
$19.4B
| $7.54M | ﹤0.01% |
50,421
+2,636
| +6% | +$359K |
|
1190
Meritage Homes
MTH
$4.75B
| $7.52M | ﹤0.01% |
73,312
+870
| +1% | +$82.1K |
|
1191
Sanmina
SANM
$11.2B
| $7.52M | ﹤0.01% |
109,781
+69,114
| +170% | +$4.77M |
|
1192
Mitsubishi UFJ Financial
MUFG
$260B
| $7.5M | ﹤0.01% |
+736,976
| New | +$7.78M |
|
|
JHG
1193
DELISTED
Janus Henderson
JHG
| $7.46M | ﹤0.01% |
195,826
-13,417
| -6% | -$485K |
|
1194
iShares MSCI India ETF
INDA
$6.58B
| $7.41M | ﹤0.01% |
126,562
+66,615
| +111% | +$3.79M |
|
1195
Ardelyx
ARDX
$1.01B
| $7.41M | ﹤0.01% |
1,074,488
-644,583
| -37% | -$3.8M |
|
1196
Thryv Holdings
THRY
$96.9M
| $7.39M | ﹤0.01% |
429,102
+1,694
| +0.4% | +$30.3K |
|
1197
GitLab
GTLB
$7.32B
| $7.33M | ﹤0.01% |
142,278
+40,467
| +40% | +$2.02M |
|
1198
Crown Holdings
CCK
$13.1B
| $7.31M | ﹤0.01% |
76,259
-133,535
| -64% | -$11.5M |
|
1199
Janux Therapeutics
JANX
$978M
| $7.24M | ﹤0.01% |
159,421
-92,937
| -37% | -$4.04M |
|
1200
Silicon Laboratories
SLAB
$7.3B
| $7.24M | ﹤0.01% |
62,642
+43,641
| +230% | +$4.87M |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.